Log In
BCIQ
Print this Print this
 

CBLB612

Also known as: Protectan CBLB612

  Manage Alerts
Collapse Summary General Information
Company Cleveland BioLabs Inc.
DescriptionSynthetic lipopeptide derived from mycoplasma
Molecular Target Toll-like receptor 2 (TLR2) ; Toll-like receptor 6 (TLR6)
Mechanism of ActionToll-like receptor 2 (TLR2) agonist; Toll-like receptor 6 (TLR6) agonist
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1.7M

$1.7M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/14/2009

$1.7M

$1.7M

0

Get a free BioCentury trial today